Search Results | Diabetes Care | American Diabetes Association

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, Andreas L. Birkenfeld, Janet B. McGill, Sylvia E. Rosas, Amer Joseph, Martin Gebel, Luke Roberts, Markus F. Scheerer, George L. Bakris, Rajiv Agarwal

Diabetes Care dc220294

DOI: https://doi.org/10.2337/dc22-0294

Published: 15 August 2022

View article

Journal Articles

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA_1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, Pieter Gillard, Richard J. MacIsaac, Julio Wainstein, Amer Joseph, Meike Brinker, Lothar Roessig, Charlie Scott, George L. Bakris

Diabetes Care 2022;45(4):888–897

DOI: https://doi.org/10.2337/dc21-1944

Published: 21 January 2022

View article

Journal Articles

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

M. Angelyn Bethel, Robert J. Mentz, Peter Merrill, John B. Buse, Juliana C. Chan, Shaun G. Goodman, Nayyar Iqbal, Neli Jakuboniene, Brian Katona, Yuliya Lokhnygina, Renato D. Lopes, Aldo P. Maggioni, Peter Ohman, Tsvetalina Tankova, George L. Bakris, Adrian F. Hernandez, Rury R. Holman

Diabetes Care 2020;43(2):446–452

DOI: https://doi.org/10.2337/dc19-1065

Published: 22 November 2019

View article

Includes: Supplementary data

Journal Articles

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes

Ian H. de Boer, George L. Bakris

Diabetes Care 2018;41(4):662–663

DOI: https://doi.org/10.2337/dci17-0053

Published: 12 March 2018

View article

Journal Articles

Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not

George L. Bakris, Mark Molitch

Diabetes Care 2018;41(3):389–390

DOI: https://doi.org/10.2337/dci17-0047

Published: 12 February 2018

View article

Journal Articles

Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS

Jan H. Cornel, George L. Bakris, Susanna R. Stevens, Michael Alvarsson, Willem A. Bax, Lee-Ming Chuang, Samuel S. Engel, Renato D. Lopes, Darren K. McGuire, Axel Riefflin, Helena Wachslicht Rodbard, Isaac Sinay, Tsvetalina Tankova, Julio Wainstein, Eric D. Peterson, Rury R. Holman

Diabetes Care 2016;39(12):2304–2310

DOI: https://doi.org/10.2337/dc16-1415

Published: 14 October 2016

View article

Includes: Supplementary data

Journal Articles

Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial

William B. White, Stuart Kupfer, Faiez Zannad, Cyrus R. Mehta, Craig A. Wilson, Lanyu Lei, George L. Bakris, Steven E. Nissen, William C. Cushman, Simon R. Heller, Richard M. Bergenstal, Penny R. Fleck, Christopher P. Cannon

Diabetes Care 2016;39(7):1267–1273

DOI: https://doi.org/10.2337/dc16-0303

Published: 12 June 2016

View article

Journal Articles

Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What’s the Fuss?

George L. Bakris, Mark E. Molitch

Diabetes Care 2016;39(7):1287–1291

DOI: https://doi.org/10.2337/dc15-2534

Published: 09 June 2016

View article

Journal Articles

Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes

Colleen Majewski, George L. Bakris

Diabetes Care 2015;38(3):429–430

DOI: https://doi.org/10.2337/dc14-1596

Published: 12 February 2015

View article

Journal Articles

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Katherine R. Tuttle, George L. Bakris, Rudolf W. Bilous, Jane L. Chiang, Ian H. de Boer, Jordi Goldstein-Fuchs, Irl B. Hirsch, Kamyar Kalantar-Zadeh, Andrew S. Narva, Sankar D. Navaneethan, Joshua J. Neumiller, Uptal D. Patel, Robert E. Ratner, Adam T. Whaley-Connell, Mark E. Molitch

Diabetes Care 2014;37(10):2864–2883

DOI: https://doi.org/10.2337/dc14-1296

Published: 10 September 2014

View article

Journal Articles

Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga

George L. Bakris, Mark Molitch

Diabetes Care 2014;37(3):867–875

DOI: https://doi.org/10.2337/dc13-1870

Published: 11 February 2014

View article

Journal Articles

Position Statement Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea Rita Horvath, M. Sue Kirkman, Ake Lernmark, Boyd E. Metzger, David M. Nathan

Diabetes Care 2011;34(6):1419–1423

DOI: https://doi.org/10.2337/dc11-9997

Published: 20 May 2011

View article

Includes: Supplementary data

Journal Articles

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea Rita Horvath, M. Sue Kirkman, Ake Lernmark, Boyd E. Metzger, David M. Nathan

Diabetes Care 2011;34(6):e61–e99

DOI: https://doi.org/10.2337/dc11-9998

Published: 20 May 2011

View article

Includes: Supplementary data

Journal Articles

Gestational Diabetes Mellitus Alone in the Absence of Subsequent Diabetes Is Associated With Microalbuminuria: Results from the Kidney Early Evaluation Program (KEEP)

Andrew S. Bomback, MD, MPH, Yelena Rekhtman, MD, Adam T. Whaley-Connell, DO, MSPH, Abhijit V. Kshirsagar, MD, MPH, James R. Sowers, MD, Shu-Cheng Chen, MS, Suying Li, PHD, Kavitha M. Chinnaiyan, MD, George L. Bakris, MD, Peter A. McCullough, MD, MPH

Diabetes Care 2010;33(12):2586–2591

DOI: https://doi.org/10.2337/dc10-1095

Published: 31 August 2010

View article

Journal Articles

Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome: Response to O'Malley, Bouldin, and Riche

George L. Bakris, MD

Diabetes Care 2007;30(4):e24

DOI: https://doi.org/10.2337/dc07-0007

Published: 01 April 2007

View article

Journal Articles

Effect of Ruboxistaurin on Urinary Transforming Growth Factor-β in Patients With Diabetic Nephropathy and Type 2 Diabetes

Richard E. Gilbert, MD, PHD, Sandra A. Kim, MD, MSC, Katherine R. Tuttle, MD, George L. Bakris, MD, Robert D. Toto, MD, Janet B. McGill, MD, Douglas J. Haney, PHD, Darren J. Kelly, PHD, Pamela W. Anderson, MD

Diabetes Care 2007;30(4):995–996

DOI: https://doi.org/10.2337/dc06-2079

Published: 01 April 2007

View article

Journal Articles

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association

John B. Buse, MD, PHD, Henry N. Ginsberg, MD, George L. Bakris, MD, Nathaniel G. Clark, MD, MS, RD, Fernando Costa, MD, Robert Eckel, MD, Vivian Fonseca, MD, Hertzel C. Gerstein, MD, MSC, FRCPC, Scott Grundy, MD, PHD, Richard W. Nesto, MD, Michael P. Pignone, MD, MPH, Jorge Plutzky, MD, Daniel Porte, MD, Rita Redberg, MD, Kimberly F. Stitzel, MS, RD, Neil J. Stone, MD

Diabetes Care 2007;30(1):162–172

DOI: https://doi.org/10.2337/dc07-9917

Published: 01 January 2007

View article

Journal Articles

Antihypertensive Therapy and the Risk of New-Onset Diabetes

Panteleimon A. Sarafidis, MD, George L. Bakris, MD

Diabetes Care 2006;29(5):1167–1169

DOI: https://doi.org/10.2337/dc06-0186

Published: 01 May 2006

View article

Journal Articles

The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes

Katherine R. Tuttle, MD, George L. Bakris, MD, Robert D. Toto, MD, Janet B. McGill, MD, Kuolung Hu, MS, Pamela W. Anderson, MD

Diabetes Care 2005;28(11):2686–2690

DOI: https://doi.org/10.2337/diacare.28.11.2686

Published: 01 November 2005

View article

NARROW

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA_1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes

Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not

Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS

Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial

Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What’s the Fuss?

Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes

Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga

Position Statement Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

Gestational Diabetes Mellitus Alone in the Absence of Subsequent Diabetes Is Associated With Microalbuminuria: Results from the Kidney Early Evaluation Program (KEEP)

Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome: Response to O'Malley, Bouldin, and Riche

Effect of Ruboxistaurin on Urinary Transforming Growth Factor-β in Patients With Diabetic Nephropathy and Type 2 Diabetes

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association

Antihypertensive Therapy and the Risk of New-Onset Diabetes

The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only